Lackluster Cancer Drug Sales Hit Roche (JOBS) Profit

February 3, 2010 |

1 min read

Reuters -- Roche Holding AG missed full-year profit forecasts due to disappointing sales of key cancer drugs and gave a lacklustre outlook for 2010, pointing to wider challenges facing global drugmakers.

Earnings

Roche

MORE ON THIS TOPIC

Business growth or increase in professional income, business operations, investment profits or interest on savings, increase in interest rates, businessman holding gold coins forming a growing arrow symbol.

Drug pricing

Pfizer Leads Industry-Wide Surge in Drug Prices for 2026 Despite Political Pressure

January 2, 2026

·

2 min read

·

Nick Paul Taylor

Abstract creative financial graph with finger clicks on a digital tablet on background, forex and investment concept.

Legal

Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme

December 23, 2025

·

2 min read

·

Nick Paul Taylor

Hands offering money with a circular chart at the center, symbolizing shareholder equity, crowdfunding, business partnerships, and investments

IPO

Radiopharma-Focused Aktis Squeezes in IPO To End Biotech Drought

December 22, 2025

·

1 min read

·

Annalee Armstrong

Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.

China

AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor

December 22, 2025

·

1 min read

·

Annalee Armstrong